Lilly and UNICEF collaborate to improve non-communicable disease prevention
Six-year initiative to improve NCD prevention and care for children in low- and middle-income countries
Read More
Section: Healthcare
Novartis breaks ground on US radioligand therapy site
The construction is part of the company’s investment in US research and manufacturing
Read More
Lilly commits additional $4.5bn for US manufacturing sites
The company has also opened its first dedicated genetic medicine facility in Indiana in the US
Read More
UCB presentation highlights impacts of epilepsy on daily life
The data underlines the consequences of disrupted sleep for patients and caregivers
Read More
Biogen agrees $850m felzartamab rights deal with TJ Biopharma
The agreement gives Biogen full global rights to the investigational antibody across immune-mediated diseases
Read More